Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Suppressing ODC activity reduces tumor growth in hair follicles.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Chemotherapy and certain hair care practices can cause severe hair matting.

Carbamazepine may cause lung problems and lupus-like symptoms, which can improve after stopping the drug.

AS101 reduces hair loss from chemotherapy.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

JAK inhibitors show promise in treating moderate to severe alopecia areata.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Platelet-rich plasma (PRP) is an effective treatment for lichen planopilaris.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Tofacitinib treatment is used for teenagers with alopecia areata.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

More research is needed to understand and treat morphea effectively.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.